v3.26.3
Interim Consolidated Statement of Changes in Shareholders’ Equity - EUR (€)
Total
Share capital
Share premium
Retained earnings
Other comprehensive income
Net income (loss)
Ordinary Shares
Ordinary Shares
Share capital
Preferred Shares
Share capital
Balance at beginning of period (in shares) at Dec. 31, 2024               83,830,336 14,075
Balance at beginning of period at Dec. 31, 2024 € 8,834,000 € 4,192,000 € 390,979,000 € (336,893,000) € 27,000 € (49,471,000)      
Changes in equity [abstract]                  
Net income (loss) (21,344,000)         (21,344,000)      
Actuarial gains (losses) on defined benefit obligations 142,000       142,000        
Foreign currency translation loss 1,025,000       1,025,000        
Total comprehensive income (loss) (20,176,000)       1,168,000 (21,344,000)      
Allocation of prior period income (loss) 0     (49,471,000)   49,471,000      
Exercise and subscription of equity instruments (in shares)               650 (5)
Exercise and subscription of equity instruments 0                
Increase capital, net (In Shares)             8,345,387    
Net Capital Increase 14,932,000 417,000 14,515,000            
Shared-based payment 1,554,000   1,554,000            
Balance at end of period (in shares) at Jun. 30, 2025               92,176,373 14,070
Balance at end of period at Jun. 30, 2025 5,144,000 4,610,000 407,048,000 (386,364,000) 1,195,000 (21,344,000)      
Balance at beginning of period (in shares) at Dec. 31, 2025               93,719,323 13,905
Balance at beginning of period at Dec. 31, 2025 (21,704,000) 4,687,000 408,033,000 (386,365,000) 1,118,000 (49,177,000)      
Changes in equity [abstract]                  
Net income (loss) (19,623,000)         (19,623,000)      
Actuarial gains (losses) on defined benefit obligations 0                
Foreign currency translation loss (253,000)       (253,000)        
Total comprehensive income (loss) (19,876,000)       (253,000) (19,623,000)      
Allocation of prior period income (loss) 0     (49,177,000)   49,177,000      
Exercise and subscription of equity instruments (in shares)               202,540 (1,558)
Exercise and subscription of equity instruments 0                
Net Capital Increase 0 10,000 (10,000)            
Shared-based payment 1,071,000   1,071,000            
Balance at end of period (in shares) at Jun. 30, 2026               93,921,863 12,347
Balance at end of period at Jun. 30, 2026 € (40,508,000) € 4,696,711 € 409,094,000 € (435,542,000) € 865,000 € (19,623,000)